Industry News
Alchemia, Mesoblast hire new CFOs
Former Mesoblast (ASX:MSB) CFO Jenni Pilcher has joined Alchemia (ASX:ACL), while former Novartis ANZ CFO
Paul Hodgkinson will fill the vacant position at Mesoblast.
[ + ]Orthocell aces tennis elbow trial
Orthocell's (ASX:OCC) autologous cell therapy Ortho-ATI improved grip strength in chronic tennis elbow patients by an average of 207% at 4.5 years post-treatment.
[ + ]ASiX highlights
The inaugural Australian Science Industry Exchange event (ASiX) was held in Melbourne last week, with over 80 of the country's science sector business and technology leaders discussing the state of the industry and seeking to find better ways to do business.
[ + ]Garvan and Roche to collaborate on epigenomic analysis
Roche Sequencing and the Garvan Institute of Medical Research have announced a collaboration to develop new technologies for targeted epigenomic analysis using DNA sequencing. [ + ]
Seeking better ways to do business at ASiX
The inaugural Australian Science Industry Exchange event (ASiX) was held in Melbourne last week, with over 80 of the country's science sector business and technology leaders discussing the state of the industry and seeking to find better ways to do business. [ + ]
Merck moving its head office
The Australian division of life science supplier Merck (Merck Millipore) is moving to a new head office. [ + ]
Laser beams to make microscopes more sensitive
Laser physicists from the Australian National University (ANU) have found a way to make atomic-force microscope probes 20 times more sensitive. [ + ]
Garvan and Roche to develop genomics technologies for epigenomic analysis
Roche Sequencing and the Garvan Institute of Medical Research have announced a two-year collaboration to develop new technologies for targeted epigenomic analysis using DNA sequencing. [ + ]
BioProcessing Network Conference 2014
The BioProcessing Network (BPN) is holding its annual conference from 21-23 October at Encore, St Kilda. The meeting will gather together researchers, manufacturers, suppliers and others with an active interest in bioprocessing as it applies to areas such as biotherapeutics, biofuels and food processing. [ + ]
Consultation begins for new Industry Skills Fund
The federal government's new $476 million Industry Skills Fund is due to commence 1 January 2015 and a consultation has commenced in preparation, which includes webinars, a discussion paper and a digital questionnaire.
[ + ]New EMBL Australia node
A partnership between the University of New South Wales and the European Molecular Biology Laboratory will set up a new EMBL Australia node. [ + ]
Bionomics posts maiden profit for FY14
Income from Bionomics' (ASX:BNO) licensing deal with Merck for Alzheimer's candidate BNC375 helped the company report its first post-tax operating profit for the last financial year. [ + ]
New centre to look at how the brain works
Understanding how the human brain works is the not so small task the new ARC Centre of Excellence for Integrative Brain Function is planning to tackle. [ + ]
Potential new standard of care for prostate cancer
A potential new standard of care is emerging for prostate cancer with a new treatment combination significantly reducing the spread of the disease as well as limiting side effects. [ + ]
Australian Genomic Technologies Association conference
The 14th Australasian Genomic Technologies Association (AGTA) conference will be held at the Crown Promenade, Melbourne, Australia, Sunday 12 to Wednesday 15 October 2014. [ + ]
